Monitoring Data Report 2021

 

The main aim and purpose of C-EHRN monitoring activities is to improve knowledge and information and complement existing data and monitoring efforts in Europe in specific areas of harm reduction based on the perspective of civil society organisations (CSOs). The data collected helps us to assess the implementation of certain drug and health policies at the national and local levels and supports our advocacy efforts at the European and EU Member State levels.

The adapted 2021 civil society monitoring incorporated the experiences from the past years. During evaluation meetings with our expert groups, it was decided to keep most of the questionnaires in 2020 intact for 2021. That was done both because the questionnaire of 2020 has worked reasonably well and also to allow for comparisons between 2021 and the previous year.

We kept our focus on the situation at the city level which allowed for more accurate and precise information. Consequently, the information provided in this report sometimes represents the situation in a particular city or region. Although this information is not representative of a country, it reflects the fact that the situation in a country is diverse and most often dependent upon the approach at the city level. Small modifications were made for clarity in the sections on essential harm reduction services, overdose prevention, Hepatitis C, civil society involvement and new drug trends. More modifications were made in the COVID-19 section to cover a new phase of the pandemic.

In addition to the survey, and on an experimental basis, the expert groups decided to try new forms of data collection. In 2 countries – Finland and the UK – online Focus Group Discussions (FGDs) will be performed to gather data on new drug trends. That was decided due to the low response rate in the online survey and also due to feedback from our Focal Points that this remains the most difficult section of the survey to complete.

More than one hundred organisations and individuals from 34 European countries have contributed to this Monitoring Report. Thanks go to our Focal Points and associated experts at the national and local levels who have filled in the online questionnaire and provided all information and data on time. Without their dedication and commitment, we would not have been able to produce this report.

Online Launch Data Report 2021

On the 1tth of May 2022, Correlation – European Harm Reduction Network launched its Civil Society Monitoring of Harm Reduction in Europe in 2021.

With the contributions of more than one hundred organizations and individuals from 34 European countries, the development and implementation of the Civil Society Monitoring Tool for Harm Reduction are one of the most important achievements of C-EHRN in recent years. The main aim of C-EHRN monitoring activities is to improve knowledge and information and complement existing data and monitoring efforts in Europe in specific areas of harm reduction based on the perspective of civil society organisations. As such, C-EHRN’s monitoring activities acknowledge the important function of civil society and harm reduction services and foster their expert role in national and European drug policy.

During this webinar, C-EHRN launched the Data Report 2021, presented its key findings and discussed them with representatives from different European organizations and institutions.

#IDUD21: International Drug Users’ Day 2021

Every year on 1st November, among many organisations, C-EHRN celebrates International Drug Users’ Day by showing solidarity within the harm reduction world, aiming to raise awareness about the importance of community-led harm reduction and peer involvement and advocate for the rights of people who use drugs.

Alongside other vital initiatives, this year, there are two campaigns to which we would like to draw your attention. 

INPUD campaign: #PowerOfPeers 
As Aditio Taslim, the INPUD Advocacy Officer, states, the COVID-19 pandemic has provided us with more proof that in times of crisis, the community responds first by extending solidarity and supporting each other through challenging times. Nevertheless, still, they are the ones that are under-funded, under-invested and excluded.

The #PowerOfPeers campaign messages boldly highlight:

By joining the Campaign, you can help add bricks to the goal to end the War on Drugs with full decriminalisation of drugs with no sanctions.

Check here for the INPUD campaign toolkit to get inspired and, accordingly, to inspire others.

UNAIDS Call-to-action
On this very day, you can also answer the call by UNAIDS for action against the criminalisation of people who use drugs and for community-led harm reduction programmes. Their call aims to end inequalities and AIDS by fully involving communities of people who use drugs to achieve legal reform aimed at decriminalisation and in the organisation of harm reduction programmes at the country level.

Lastly, as you might be well aware, the 5th European Harm Reduction Conference will occur next week between 10-12 November in Prague. The programme includes extensive highlights which are co-organised by representatives of people who use drugs and peer-led networks. 

Below are only a couple of the sessions that will touch the groundwork and offer plenty of discussions and knowledge exchange: 

  1. Workshop 3 | C-EHRN & EuroNPUD: A starters kit for testing in the community by the community
  2. Satellite II | UNODC HIV/AIDS Section – HIV prevention, treatment and care among & with people who use stimulant drugs
  3. Plenary Opening Session | Drug policy and harm reduction embedded into the broader development of societies in Europe
  4. Major Session 1 | Drug policy decriminalisation
  5. Major Session 4 | Key issues during the pandemic: naloxone and overdoses
  6. Parallel Session 2 | Peer-led Harm Reduction
  7. Parallel Session 3 | Girls Power in HR2
  8. Parallel Session 7 | Supporting person-centred choice
  9. Parallel Session 8 | NPS and mental health
  10. Parallel Session 10 | Objects or Subjects?
  11. Major Session 5 | Peer work and research

Did you know that there will also be live-streaming sessions?
Check out their list and register here if your calendar can be shifted to open room for those you fancy following!

COVID-19 Resource Centre

To support people who use drugs and other marginalized and underserved communities, as well as health and social workers delivering services under challenging conditions to bring this outbreak to a close, Correlation – European Harm Reduction Network is developing this Coronavirus Resource Centre. This capacity-building initiative complements our advocacy activities and the Joint Position on the Continuity of Harm Reduction Services During the COVID-19 Crisis that we published together with the Eurasian Harm Reduction Network, and the Rights Reporter Foundation

This Resource Centre brings together contributions, materials, experiences of our members, partners and allies. New/Updated materials come first, as situations change very quickly.

If you discover any out-of-date links or if there would be any links that could be included, please, let us know at this address: rpgayo@correlation-net.org

 

STATEMENTS | POSITION PAPERS | ADVOCACY

Coalition Plus, IDPC, HRI, INPUD, C-EHRN, INHSU, TAG | COVID-19: An Opportunity For POlicy Reform [June, 26th]

RCC-THV | Call to Action in Response to COVID-19 [May, 14th]

UNAIDS | Sex Workers Must not be Left Behind in the Response to COVID-19 [April, 8th]

TGEU | COVID-19 & Trans People [April, 6th]

INPUD, HRI, EHRA, IDPC et al | Call to Action COVID-19 – Special Rapporteur on the Right to Health [March, 31st]

Nobody Left Outside | EU and national government COVID-19 responses must reach everyone – including marginalised people [March, 26th]

UN Human Rights Experts | No Exceptions with COVID-19: Everyone Has the Right to Live-Saving Interventions | [March, 26th]

EATG | EATG statement on the evolving COVID-19 pandemic [March, 25th]

PICUM | The COVID-19 pandemic: We Need Urgent Measures to Protect People and Mend the Cracks in our Health, Social Protection and Migration Systems [March, 25th]

EUPHA | Statement by the EUPHA Migrant and ethnic minority health section on COVID-19 – CALL FOR ACTION [March, 24th]

UNAIDS | Rights in the time of COVID-19. Lessons from HIV for an effective, community-led response | Infographic | [March, 20th]

C-EHRN & EHRA | Harm Reduction Must Go On [March, 19th]

Human Rights Watch | Human Rights Dimensions of COVID-19 Response [March, 19th]

Global Rights / Susanna Ronconni | Prisoners Rights Matter! Statement | Article [March, 19th]

FEANTSA | COVID-19: “Staying Home” Not an Option for People Experiencing Homelessness [March, 18th]

ICRSE | COVID-19: Sex Workers Need Immediate Financial Support and Protection [March, 18th]

Penal Reform International | Coronavirus: Healthcare and Human Rights of People in Prison [March, 16th]

DPNSEE | Public Appeal to Protect Vulnerable Groups from COVID-19 [March, 2nd]

 

GUIDELINES | PROTOCOLS | GOOD PRACTICE

 

DRUG USE

EHRA | Harm reduction service delivery to people who use drugs during a public health emergency: Examples from the COVID-19 pandemic in selected countries [November 2020]

Manitoba Harm Reduction Network | Outreach Guidelines During COVID-19 [Updated, March, 26th]

EuroNPUD & INPUD & Respect Drug Users Rights | COVID-19: Advice for People who Use Drugs [March, 26th]

Forum Substitution Praxis | Newsletters on COVID-19 and Substitution Treatment [GER] [Update Daily]

Drug Reporter | How Harm Reducers Cope with the COVID-19 Pandemic in Europe? [Last update: March, 20th]

MAINline | 8 Corona-Tips voor Mensen die Drugs Gebruiken [NL] [March, 20th]

AFEW International | Mental Health & Psychological Considerations during COVID-19 Outbreak [March, 20th]

Scottish Drug Forum | Guidance on Contingency Planning for People who Use Drugs and COVID-19 (v1.0) [March, 19th]

Echele Cabeza | Consumo de Sustancias Psycoactivas en Cuarentena [SP] [March, 19th]

Zurich Drug Consumption Rooms | COVID-19 Protocols [March, 19th]

Metzineres | COVID-19 Harm Reaction Poster | Flyer (front) | Flyer (back) [March, 19th]

Energy Control | Party & Drugs in the Time of Coronavirus [March, 19th]

YALE | COVID-19 Guidance: Clinicians & Opioid Treatment Programs [March, 18th]

YALE | COVID-19 Guidance: Patients Engaged in Substance Use Treatment [March, 18th]

YALE | Guidance for People Who Use Substances on COVID-19 [March, 18th]

Arild Knutsen | An Open Letter on COVID-19 and PWUD [March, 17th]

DPNSEE | Instructions on Coronavirus for PWUD [Serb] [March, 16th]

Quality Assurance Commission for Substitution Treatment in Germany | Information on Opioid Substitution and COVID-19 – Advice for Physicians [March, 16th]

LANPUD | Drogas y COVID-19 [SP] [March, 14th]

INPUD | Harm Reduction for People Who Use Drugs [March, 13th]

Drug Policy Network SEE | Basic Protective Measures Against the New Coronavirus [March, 11th]

HRC | Safer Drug Use During the COVID-19 Outbreak [March, 11th]

HRC | Syringe Services and Harm Reduction Provider Operations During the COVID-19 Outbreak [March, 11th]

CREW | Coronavirus – General Hygiene Harm Reduction Tips [March, 4th]

 

SEX WORK

ICRSE | Sex Workers Response to COVID-19 in Europe and Central Asia [continuosly updated]
NYC Health | Information on Safer Sex during COVID-19 [March, 21st]
Butterfly Asian and Migrant Sex Workers Support Network & Maggie’s Toronto Sex Workers Action Project |Sex work COVID-19: Guidelines for Sex Workers, Clients, Third Parties, and Allies [March, 19th]

 

GENDER & SEXUAL ORIENTATION

Metzineres | Woman & Gender Non-Conforming People Who Use Drugs Surviving Violence During Quarantine [April, 8th]
NYC Health | Information on Safer Sex during COVID-19 [March, 21st]
GMSH | COVID-19: 2GBTQ MEN [March, 20th]
David Stuart | What does coronavirus (COVID-19) mean in regard to Chemsex? [March, 19th]
Energy Control | Party & Drugs in the Time of Coronavirus [March, 19th]

 

CAPACITY BUILDING

STUDIES | REPORTS | ARTICLES

WEBINARS

FEANTSA | COVID19 & Rough Sleepers [June, 10th]

ISAM | 3rd Webinar on COVID19 and Substance Use [May, 7th]

Alliance for Public Health | COVID-19 Lessons: What can make HIV programs in EECA countries more sustainable? [May, 5th]

ISAM | 2nd Webinar on COVID19 and Substance Use [April, 15th]

INPUD, Medicines du Mond, HRI, UNDOC, WHO | COVID-19 Harm Reduction Programme Implementation [April, 6th]

International AIDS Society | COVID-19 & HIV: What you Need to Know [April, 3rd]

EU Health Policy Platform | COVID-19 European Coordinated Response to the Pandemic [April, 3rd]

CATIE |  Coping with COVID-19: Insight from the Front Lines of HIV, Hepatitis C & Harm Reduction [March, 26th]

Institute for Interdisciplinary Innovation in Healthcare | COVID-19: a Systemic Crisis [March, 25th]

ICPA | Response to COVID-19 in Prisons | Slides | [March, 19th]

ISAM | COVID-19 and Substance Dependence [March, 19th]

Foundation for Opioid Response Efforts | Medications for Opioid Use Disorder and the COVID-19 [March, 19th]

HRC | Harm Reduction, COVID-19, and People Who Use Drugs [March, 18th]

 

PODCASTS

Crack Down |Emergency Measures [March, 20th]

Ten Percent Happier with Dan Harris |How to Handle Coronavirus Anxiety | Special Edition [March, 14th]

Healing Justice | Coronavirus: Wisdom from a Social Justice Lens [March, 13th]

Statement: Harm Reduction Must Go On!

Correlation – European Harm Reduction Network and the Eurasian Harm Reduction Association, together with the Rights Reporter Foundation, published a joint position on the continuity of harm reduction services during the COVID-19 crisis.

Download the English, Russian, German, Portuguese, Spanish, Polish, Hungarian, Czech, Montenegrin PDF version here!

People Who Use Drugs (PWUDs) can be considered as a risk group in the COVID-19 epidemic. They often live at the margins of society with low or no access to housing, employment, financial resources, social and health care, and face systematic discrimination and criminalisation in the majority of countries. Many of them have multiple health problems, which can increase the risk of a (fatal) COVID-19 infection (including long-term diseases such as COPD, HIV, TB, cancer, and other conditions which reduce the immune system). Harm reduction services are often the one and only contact point for PWUDs to access the health service. They provide health and social services as well as other basic support, and function as an essential link to other life-saving services. We call on local and national governments and international organisations introducing safety measures and to:

1. Ensure the continuity and sustainability of harm reduction and other low-threshold services for PWUDs during the COVID-19 epidemic. This includes, in particular, Opiate Substitution Treatment (OST), Heroin Assisted Treatment (HAT), Needle and Syringe Programs (NSP), naloxone provision, and continued access to Drug Consumption Rooms (DCRs). In addition, essential basic services need to be provided, including day and night shelter, showers, clothing, food, and other services. This is of particular importance to those who experience homelessness and/or live on the streets.

2. Provide adequate funding for harm reduction and other low-threshold service providers, and supply them with adequate equipment to protect staff and clients from infections (soap, hand sanitiser, disposable face-masks, tissues etc.).

3. Acknowledge the important and critical role of harm reduction and other low-threshold services in the COVID-19 pandemic and address the specific vulnerable situation of PWUDs and other related groups.

4. Develop specific guidelines and regulations for harm reduction services, with respect to the vulnerable situation of PWUDs and related target groups. These guidelines should be developed in close cooperation with involved staff and the affected communities, and build on international WHO guidelines, recommendations, and evidence and/or national COVID-19 regulations.

More specifically we call for the following:

5. OST and HAT should be maintained and take-home regulations should be established or extended for patients to have the opportunity to come for treatment rarely then ones a week. Access through pharmacies should be ensured.

6. NSP should provide PWUDs with larger amounts of needles, syringes, and other paraphernalia to minimise the number of contacts. Special bins for needles and syringes should be provided to collect used material at home.

7. Harm reduction services should provide COVID-19 prevention material and information for staff, volunteers, and service users, including soap, alcohol-based hand sanitisers that contain at least 60% alcohol, tissues, trash baskets, and disposable face-masks (if this is requested by national regulations), for people who show symptoms like fever, coughing, and sneezing.

8. Drop-in services, day shelters, and DCRs should advise and support PWUDs in preventing COVID-19 infections. Visitors should be made to sanitise their hands when entering and should stay no longer than is absolutely necessary. Kitchens can prepare take-away food to be eaten outdoors. All necessary measures should be made to increase social distancing among visitors/staff with all possible means, and rooms should be ventilated. Overcrowding in harm reductions services, shelters, and DCRs should be avoided, by establishing safety measures, e.g. minimising the duration of stay, maximum number of visitors, entering only once per day. People with permanent housing should be encouraged to stay at home and come only to pick up needles and other harm reduction paraphernalia and tools.

9. The health situation of PWUDs should be monitored closely. If someone shows symptoms, such as fever and coughing, face-masks should be provided and a medical check-up should be ensured. Cooperation agreements with public health services, related health units, and hospitals need to be established to ensure direct medical support, follow up care, and treatment.

10. Night shelters need to be made available for people experiencing homelessness, with a separation in place between those who are not infected and those who are infected and need to be quarantined but do not need specific medical care and treatment in hospitals. Night shelters have to comply with the overall safety regulations for COVID-19, and people should not be exposed to additional risks for infection through overcrowding and insufficient health care.

11. Group-related services, such as meetings and consultations, should be cancelled and postponed until further notice or organised as online services. New treatment admissions should be temporarily suspended. Coercive measures (e.g treatment referrals made by court/prosecutor/police, probation officer visits etc.) should be suspended. Mandatory urine sampling should be abolished.

12. Harm reduction services should establish a safe working environment and make sure that staff are well informed and protected against infection. Service providers should identify critical job functions and positions, and plan for alternative coverage by involving other staff members in service delivery.